2017/1 GaBI Journal Table of Contents

Contents

Editor’s Letter

Editor’s introduction to the initial issue of the sixth volume of GaBI Journal

Letters to the Editor

Pricing strategies for pharmaceuticals in developing countries: what options do we have?

Original Research

Naming and labelling of biologicals – a survey of US physicians’ perspectives

Review Article

Ocular emulsions and dry eye: a case study of a non-biological complex drug product delivered to a complex organ to treat a complex disease

Perspective

Pharmacovigilance of biosimilars and other biologicals within the hospital: current practices and future challenges

Special Report

Patent expiry dates for biologicals: 2016 update

Meeting Report

Roundtable on biosimilars: pharmacovigilance, traceability, immunogenicity, 15 November 2016, Madrid, Spain

Biosimilar product labels in Europe: what information should they contain?

Opinion

Austrian medicines authority positive towards biosimilar interchangeability

Pharma News

Top developments in biosimilars during 2016

Sponsored Article

Next generation processing of monoclonal antibodies

Source URL: https://gabi-journal.net/20171-gabi-journal-table-of-contents.html